Non-Pharmacological approaches to the prevention and treatment of Alzheimer's disease with respect to the rising treatment costs
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00179906%3A_____%2F16%3A10331020" target="_blank" >RIV/00179906:_____/16:10331020 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/62690094:18450/16:50004956
Výsledek na webu
<a href="http://dx.doi.org/10.2174/1567205013666151116142302" target="_blank" >http://dx.doi.org/10.2174/1567205013666151116142302</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.2174/1567205013666151116142302" target="_blank" >10.2174/1567205013666151116142302</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Non-Pharmacological approaches to the prevention and treatment of Alzheimer's disease with respect to the rising treatment costs
Popis výsledku v původním jazyce
Alzheimer's disease is a serious degenerative disease which is mainly typical of the developed countries. The prevalence percentage in Africa is only 2.6 %, whereas in America it is 6.5 % and in Western Europe 7.2 %. Overall, this disease affects 44 million people worldwide. With respect to the demographic development, a number of people suffering from Alzheimer's disease is expected in future. The key issue is not only the discovery of an effective medication, but also the early diagnosis, prevention and care about people with AD, as well as the provision of an equivalent rise of places in health and social institutions. Since the treatment of Alzheimer's disease (AD) imposes a severe economic and social burden, the main purpose of this study is to analyze and compare available non-pharmacological approaches to the prevention and treatment of patients with AD with special focus on their cognitive competences. In addition, the analysis also concentrates on the costs of pharmacological care in individual countries all over world. This is done by using Drummond's methodological approaches to direct and indirect costs. The analysis of non-pharmacological approaches is conducted on the basis of literature review of both clinical and review studies relevant for the research issue in the acknowledged databases and a comparison and evaluation of their findings.
Název v anglickém jazyce
Non-Pharmacological approaches to the prevention and treatment of Alzheimer's disease with respect to the rising treatment costs
Popis výsledku anglicky
Alzheimer's disease is a serious degenerative disease which is mainly typical of the developed countries. The prevalence percentage in Africa is only 2.6 %, whereas in America it is 6.5 % and in Western Europe 7.2 %. Overall, this disease affects 44 million people worldwide. With respect to the demographic development, a number of people suffering from Alzheimer's disease is expected in future. The key issue is not only the discovery of an effective medication, but also the early diagnosis, prevention and care about people with AD, as well as the provision of an equivalent rise of places in health and social institutions. Since the treatment of Alzheimer's disease (AD) imposes a severe economic and social burden, the main purpose of this study is to analyze and compare available non-pharmacological approaches to the prevention and treatment of patients with AD with special focus on their cognitive competences. In addition, the analysis also concentrates on the costs of pharmacological care in individual countries all over world. This is done by using Drummond's methodological approaches to direct and indirect costs. The analysis of non-pharmacological approaches is conducted on the basis of literature review of both clinical and review studies relevant for the research issue in the acknowledged databases and a comparison and evaluation of their findings.
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
AH - Ekonomie
OECD FORD obor
—
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2016
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Current Alzheimer Research
ISSN
1567-2050
e-ISSN
—
Svazek periodika
13
Číslo periodika v rámci svazku
11
Stát vydavatele periodika
AE - Spojené arabské emiráty
Počet stran výsledku
10
Strana od-do
1249-1258
Kód UT WoS článku
000390335400005
EID výsledku v databázi Scopus
2-s2.0-84995752432